Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection

Journal of Pediatric Gastroenterology and Nutrition

Volumn 45, Issue 1, 2007, Pages 75-83

  Fischler, Björn ^a   Nyström, Jessica ^a   Björnsdottir, Thora ^a   Lindh, Gudrun ^a   Hultgren, Catharina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytokines; Genotype; Interferon treatment; T cell proliferation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CYTOKINE; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; T LYMPHOCYTE;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CHILD; CYTOKINES; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; T-LYMPHOCYTES; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 34347358579     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31804a85ce     Document Type: Article

References (25)

1. Slowik MK, Jhaveri R. Hepatitis B and C viruses in infants and young children. Semin Pediatr Infect Dis 2005;16:296-305.
2. Arakawa K, Tsuda F, Takahashi K, et al. Maternofetal transmission of IgG-bound hepatitis B e antigen. Pediatr Res 1982;16:247-50.
3. Milich DR, Jones JE, Hughes JL, et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A 1990;87:6599-603.
4. Wang JS, Zhu QR. Infection of the fetus with hepatitis B e antigen via the placenta. Lancet 2000;355:989.
5. Jara P, Bortolotti F. Interferon-alpha treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J Pediatr Gastroenterol Nutr 1999;29:163-70.
6. Sokal EM, Kelly DA, Mizerski J, et al. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 2006;43:225-32.
7. Ferrari C, Penna A, Bertoletti A, et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990;145:3442-9.
8. Vingerhoets J, Michielsen P, Vanham G, et al. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B. J Hepatol 1998;28:8-16.
9. Szkaradkiewicz A, Jopek A, Wysocki J, et al. HBcAg-specific cytokine production by CD4 T lymphocytes of children with acute and chronic hepatitis B. Virus Res 2003;97:127-33.
10. Bjornsdottir TB, Stanzeit B, Sallberg M, et al. Changing prevalence of hepatitis B virus genotypes in Iceland. J Med Virol 2005;77:481-5.
11. Hultgren C, Weiland O, Milich DR, et al. Cell-mediated immune responses and loss of hepatitis B e-antigen (HBeAg) during successful lamivudine and famciclovir combination therapy for chronic replicating hepatitis B virus infection. Clin Infect Dis 1999;29: 1575-7.
12. Kellar KL, Kalwar RR, Dubois KA, et al. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 2001;45:27-36.
13. Yeo W, Chan PK, Zhong S, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 2000;62:299-307.
14. Kawatani T, Suou T, Tajima F, et al. Incidence of hepatitis virus infectionand severe liverdysfunction inpatients receivingchemotherapy for hematologic malignancies. Eur J Haematol 2001;67:45-50.
15. Boni C, Bertoletti A, Penna A, et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998;102: 968-75.
16. Webster GJ, Reignat S, Brown D, et al. Longitudinal analysis of CD8p T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 2004;78:5707-19.
17. Hsu HY, Chang MH, Ni YH, et al. Cytokine release of peripheral blood mononuclear cells in children with chronic hepatitis B virus infection. J Pediatr Gastroenterol Nutr 1999;29:540-5.
18. Avanzini MA, Belloni C, De Silvestri A, et al. Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: evaluation of T helper lymphocyte diversity. Clin Immunol 2003;107:122-8.
19. Kao JH, Chen PJ, Lai MY, et al. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol 2004;72:363-9.
20. Ni YH, Chang MH, Wang KJ, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 2004;127:1733-8.
21. Chang MH. Natural history of hepatitis B virus infection in children. J Gastroenterol Hepatol 2000;15 (Suppl):E16-9.
22. Bortolotti F, Jara P, Crivellaro C, et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 1998;29:184-90.
23. Ruiz-Moreno M. Chronic hepatitis B in children: natural history and treatment. J Hepatol 1993;17 (Suppl 3):S64-6.
24. Vo Thi Diem H, Bourgois A, Bontems P, et al. Chronic hepatitis B infection: long-term comparison of children receiving interferon alpha and untreated controls. J Pediatr Gastroenterol Nutr 2005;40: 141-5.
25. Bortolotti F, Jara P, Barbera C, et al. Long-term effect of alpha interferon in children with chronic hepatitis B. Gut 2000;46: 715-8.